Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
HeartFlow, Inc. is a medical technology company transforming the diagnosis and management of coronary artery disease (CAD), the most common form of heart disease. Their flagship product, the HeartFlow FFRct Analysis, is a non-invasive technology that creates a personalized 3D model of a patient's coronary arteries from a standard CT scan. This analysis provides physicians with detailed information about blood flow and blockages, helping them make more informed treatment decisions, potentially avoiding unnecessary invasive procedures. HeartFlow aims to improve patient outcomes, reduce healthcare costs, and enhance the efficiency of cardiac care globally.
The Redwood City headquarters serves as the central hub for HeartFlow's global operations, including research and development, engineering, corporate strategy, marketing, sales leadership, and administrative functions.
The facility is a modern office space designed to foster collaboration and innovation, likely equipped with advanced computing infrastructure for its AI-driven image analysis and R&D labs.
HeartFlow's work culture is characterized by a strong mission-driven focus on improving patient lives, innovation, collaboration across multidisciplinary teams, and a fast-paced environment typical of a leading-edge technology company in the medical field.
Its Silicon Valley location provides access to a rich talent pool in software engineering, AI, medical device development, and venture capital, crucial for HeartFlow's growth and innovation.
HeartFlow supports its global operations through strategic offices in North America, Europe, and Asia, with a primary focus on sales, marketing, clinical support, regulatory affairs, and continued research and development. They work with hospitals, healthcare systems, and physicians worldwide to integrate the HeartFlow Analysis into cardiac care pathways.
1400 Seaport Boulevard, Building B, Suite 500
Redwood City
CA
USA
Address: Information not publicly detailed, but serves as a key European hub.
To expand the adoption and utilization of HeartFlow FFRct Analysis across Europe, providing localized support and expertise.
Address: HeartFlow Japan G.K., Marunouchi Nijubashi Building, 2-2 Marunouchi 3-chome, Chiyoda-ku, Tokyo
To drive growth and establish HeartFlow's technology as a standard of care for diagnosing CAD in Japan.
Address: Specific address not widely publicized for a general office; may be engineering or support focused.
To augment R&D capabilities and provide operational support, diversifying talent locations within the US.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Heartflow' leadership includes:
Heartflow has been backed by several prominent investors over the years, including:
Publicly available information regarding specific executive new hires or exits at HeartFlow, Inc. within the last 12 months is limited. Major C-suite changes are typically announced via press releases or company updates. No prominent announcements of this nature were found for the immediate past year through general searches.
Discover the tools Heartflow uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
HeartFlow, Inc. likely uses common corporate email formats. Based on industry patterns and available data, the most probable primary email format is [first_initial][last]@[companydomain.com].
flast@heartflow.com
Format
jsmith@heartflow.com
Example
80%
Success rate
HeartFlow News • February 27, 2024
HeartFlow and the American College of Cardiology (ACC) have announced a collaboration to improve heart disease diagnosis and care. This partnership will leverage HeartFlow's Plaque Analysis technology and ACC's NCDR CathPCI Registry data to provide insights into coronary artery disease....more
HeartFlow News • November 14, 2023
HeartFlow received FDA 510(k) clearance for its RoadMap™ Analysis v3.0. This enhanced version provides improved coronary artery anatomy and plaque assessment, aiding physicians in diagnosing and treating coronary artery disease....more
PR Newswire • September 26, 2023
HeartFlow appointed two new leaders to its Medical Affairs team, Dr. Odayme Quesada as Medical Director of Health Equity and Access, and Dr. Faisal Nabi as Medical Director of Strategic Initiatives. These appointments aim to expand access to HeartFlow's technology and address health disparities....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Heartflow, are just a search away.